Navigation Links
Protein Tomography(TM) Reveals Molecular Mode of Action of Humax-EGFr Published in PNAS
Date:4/22/2008

y(TM) and we are proud to have contributed to Genmab's new insight to HuMax-EGFr mechanism of action." says Hans Johansson CEO at Sidec AB.

The new findings will be published in the journal Proceedings of the National Academy of Science of the United States of America (PNAS) in the edition published on April 21, 2008

About Sidec

Sidec studies molecular interactions in situ and in vitro using its proprietary technology Protein Tomography(TM). Sidec AB offers collaboration research projects to the biopharmaceutical industry and reveals unique information to prioritize the most promising therapeutic antibody and to locate the antibody binding epitope.

For more information, please contact:

Mr.Hans Johansson, CEO

Phone: +46(0)8-4777-602

http://www.sidec.com


'/>"/>
SOURCE Sidec AB
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Nostrum Announces the Successful Completion of Early Proof-of-Concept Study for its Novel Clot Busting Therapeutic Protein
2. Arriva Pharmaceuticals Moves Forward to Phase 2b Development of Lead Inhaled Protein rAAT Replacement Therapy for Hereditary Emphysema
3. NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the GTCbio Cancer Drugs Research & Development Conference
4. Fundamental Applied Biology, Inc. Is Awarded SBIR Phase IIB Grant for the Commercialization of Protein Therapeutics Using Cell Free Technology
5. Neptune Industries Reports Favorable Phase II Trial Results on Ento- Protein(TM)
6. VioQuest Pharmaceuticals Announces Dosing of First Patient in Phase IIa Solid Tumor Study for Lenocta(TM), a Novel Protein Tyrosine Phosphatase Inhibitor
7. The New England Journal of Medicine Publishes First Clinical Results for MedImmunes Chitinase-like Protein YKL-40 in Patients With Asthma
8. First High-Res 3-D Structures of Mammalian HSP90 Protein Solved, Key to Better Targets for AIDS, Sepsis, Cancer Drugs
9. Exelixis Reports Top-Line Results of the Phase 2 Trial of XL784 in Patients With Proteinuria Associated With Diabetic Nephropathy
10. Vical Demonstrates Dose-sparing of Protein-based H5N1 Influenza Vaccine With Vaxfectin(TM) Adjuvant
11. Study Suggests Soy Protein May Reduce Prostate Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... , Aug. 3, 2015  Sage Analytics ( ... portable laboratory-quality cannabis potency measurement systems, announced its sponsorship ... Area Cruise Fundraiser. A limited number of tickets are ... and help a great cause while enjoying an open ... cruise around the San Francisco Bay at sunset. ...
(Date:8/3/2015)... Aug. 3, 2015   ConvergeHEALTH by ... Allergan plc is expanding its year-long ... Intermountain Healthcare to include women,s health.  ... analytics platform to generate real-world clinical insights in ... "We look forward to expanding our work with ...
(Date:8/3/2015)... SPRINGS, Florida , August 3, 2015 ... development agreements between biotech companies, military surgical ... solutions & therapies with regards to severe ... positive clinical enhancements for regenerative medicine and ... recent developments, partnerships and advancements in focus ...
Breaking Medicine Technology:Sage Analytics Sponsors California Cannabis Industry Association Bay Area Cruise FUNdraiser 2ConvergeHEALTH by Deloitte and Intermountain Healthcare Expand Real World Evidence Collaboration with Allergan to Focus on Women's Health 2ConvergeHEALTH by Deloitte and Intermountain Healthcare Expand Real World Evidence Collaboration with Allergan to Focus on Women's Health 3ConvergeHEALTH by Deloitte and Intermountain Healthcare Expand Real World Evidence Collaboration with Allergan to Focus on Women's Health 4Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 2Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 3Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 4Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 5Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 6
... Still River Systems, Inc. announces today that ... with the Massachusetts Institute of Technology (M.I.T.) to ... Plasma Science and Fusion Center in collaboration with ... in conjunction with its own leading-edge developments in ...
... Neuland Laboratories Ltd., a pharmaceutical manufacturer providing active pharmaceutical ... services to customers located in 85 countries, today announced ... manufacture at the 22nd American Peptide Symposium to be ... "It is fitting that we formally launch our ...
Cached Medicine Technology:Still River Systems Sign Patent License Agreement With the Massachusetts Institute of Technology 2Neuland Labs Launches Expanded Peptide Manufacturing Capabilities at 22nd American Peptide Symposium 2Neuland Labs Launches Expanded Peptide Manufacturing Capabilities at 22nd American Peptide Symposium 3
(Date:8/3/2015)... CA (PRWEB) , ... August 03, 2015 , ... Representatives ... a Nutritionist” service on its website. , “Our ‘Ask a Nutritionist’ feature on our ... how to eat healthily,” said Liza Brisk, nutritionist and spokeswoman for Health Food Grocers. ...
(Date:8/3/2015)... UT (PRWEB) , ... August 03, 2015 , ... ... of the T500 cable , a Bluetooth Code Reader accessory that enables a ... iOS products. The T500 helps enable a variety of barcode reading applications with ...
(Date:8/3/2015)... Los Angeles, California (PRWEB) , ... August 03, ... ... post on the Atlanta Journal Constitution, the new Lifetime reality series, “Atlanta ... to who performs and who receives plastic surgery, with its predominantly African-American cast ...
(Date:8/3/2015)... ... August 03, 2015 , ... They know every second counts. And when it ... offers some of the best care in the nation. For the past two months, ... average blood clot removal time in the country. During the months of June and ...
(Date:8/3/2015)... ... August 03, 2015 , ... Kantor & ... favor of the firm’s client Rebecca Hamsher, deciding that in accordance with ERISA ... benefits for Hamsher’s residential treatment for bulimia, depression and other mental health problems. ...
Breaking Medicine News(10 mins):Health News:Health Food Grocers Launches "Ask a Nutritionist" Service 2Health News:Health Food Grocers Launches "Ask a Nutritionist" Service 3Health News:Code Launches the T500, an Innovative Code Reader Accessory 2Health News:Code Launches the T500, an Innovative Code Reader Accessory 3Health News:Article on Lifetime’s New “Atlanta Plastic” Reality Series Underlines the Diversity of Today’s Plastic Surgery Patients, Says Plastic Surgeon Dr. J 2Health News:Article on Lifetime’s New “Atlanta Plastic” Reality Series Underlines the Diversity of Today’s Plastic Surgery Patients, Says Plastic Surgeon Dr. J 3Health News:Providence St. Vincent Stroke Care Recognized Among Best in the Country 2Health News:Providence St. Vincent Stroke Care Recognized Among Best in the Country 3Health News:Kantor & Kantor Announces North Cypress Medical Center Must Reimburse Benefits for Mental Health Treatment 2Health News:Kantor & Kantor Announces North Cypress Medical Center Must Reimburse Benefits for Mental Health Treatment 3
... Projects Significant Expansion of Drug-Treated Population, But Only For ... New ... from Decision Resources, WALTHAM, Mass., Sept. 5 Decision Resources, ... and,healthcare issues, has found that a significant proportion of hepatitis C,virus ...
... Technology Services, or,CTS, (http://www.ctsmius.com ) announced that ... the most stringent medical devices by,the Food and ... company,is continuing to focus on its growth in ... the company from well-known automotive supplier,MSX International, last ...
... Than 35 Doctors Grow as MedHelp Focuses on Answering More ... Consumer ... the leading online,health community connecting people to medical experts, information ... L. Johnson, M.D. and Stephen Ryu, M.D. have joined their,premier ...
... Award-Winning ... Technology of AnyTrack GPS-100 Model, IRVINE, Calif., Sept. ... of GPS tracking products and services,announced two enhanced GPS ... the GPS-100. The new AnyTrack GPS-130 is a ...
... Symbol: AKL, MONTREAL, Sept. 5 /PRNewswire-FirstCall/ ... development company focused on developing therapies for ... positive results from the,double-blind extension part of ... demonstrated statistically significant differences compared to,placebo in ...
... 2007) Today, the Canadian Institutes of Health Research ... to the results of research it has funded. CIHR ... research articles are freely available online within six months ... to research findings is a defining feature of science, ...
Cached Medicine News:Health News:Burgeoning Population of Hepatitis C Virus Patients in Need of Second- and Third-Line Treatment Options 2Health News:Creative Technology Services Enhances its Global Competitiveness with Additional Regulatory Certifications 2Health News:MedHelp to Add Top Stanford Surgeons and Specialized Forums to Online Health Community 2Health News:MedHelp to Add Top Stanford Surgeons and Specialized Forums to Online Health Community 3Health News:New AnyTrack GPS Devices Track Assets Indoors, Outdoors or Hidden 2Health News:New AnyTrack GPS Devices Track Assets Indoors, Outdoors or Hidden 3Health News:AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial 2Health News:AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial 3Health News:Open access to health research publications 2
... The Nidek's ophthalmic Nd: YAG laser ... featured system of superb versatility and clinical ... YAG Laser (1064nm),, Lightweight Model ,Further ... more convenient setting in your office.,, ...
... delivers a solid-state green laser ... and plugs into any standard ... and extreme portability, the unit ... Nidek Phaco Emulsification System CV-24000 ...
... technology is an effective angina ... with poor targets. Because it ... suites, the CO2 Heart Laser ... make timely operative decisions to ...
Ultrasensitive TSH EIA Thyroid Function 025-BC-1003...
Medicine Products: